ARTICLE | Clinical News
Architect HBsAg Qualitative II assay regulatory update
November 14, 2011 8:00 AM UTC
Abbott received CE Mark approval for its Architect HBsAg Qualitative II assay to aid in the diagnosis of HBV infection and for screening donated blood and plasma. The chemiluminescent microparticle im...